At a glance
- Originator NAEJA Pharmaceutical
- Class Antifungals; Piperazines; Triazoles
- Mechanism of Action 14-alpha demethylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 30 Nov 2004 Discontinued - Preclinical for Mycoses in Canada (PO)
- 30 Nov 2004 Discontinued - Preclinical for Mycoses in Japan (PO)
- 04 Oct 2004 Essential Therapeutics has closed down